SCHEMBL14839484

SCHEMBL14839484

COc1ccc(/C=C/C(O)c2ccc(C(C)C)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
CYP3A4 P08684 2/20 0.54
MAPT P10636 1/20 0.54
CYP2C9 P11712 1/20 0.54
ALOX15 P16050 1/20 0.54
CYP2C19 P33261 1/20 0.54
AHR P35869 2/20 0.47
MEN1 O00255 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 3/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
CYP1A1 P04798 3/20 0.45
CYP1B1 Q16678 3/20 0.45
CYP1A2 P05177 2/20 0.45
PTGS2 P35354 2/20 0.45
ALOX12 P18054 1/20 0.45
PTGS1 P23219 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14839479 1.00 ALDH1A1 (0.54) ALDH1A1CYP3A4MAPTCYP2C9ALOX15
SCHEMBL14839505 0.93 ALDH1A1 (0.60) ALDH1A1CYP3A4MAPTCYP2C9ALOX15
SCHEMBL14839478 0.88 KDM4E (0.53) ALDH1A1CYP3A4MAPTCYP2C9ALOX15
SCHEMBL4632481 0.85 TRPA1 (0.59) ALDH1A1CYP3A4MAPTCYP2C9ALOX15
SCHEMBL4631951 0.85 TRPA1 (0.59) ALDH1A1CYP3A4MAPTCYP2C9ALOX15
SCHEMBL4632483 0.85 TRPA1 (0.59) ALDH1A1CYP3A4MAPTCYP2C9ALOX15
SCHEMBL4631947 0.85 TRPA1 (0.59) ALDH1A1CYP3A4MAPTCYP2C9ALOX15
SCHEMBL18608170 0.84 RELA (0.61) ALDH1A1CYP3A4MAPTCYP2C9CYP2C19
SCHEMBL9448707 0.83 SLC2A1 (0.57) ALDH1A1CYP3A4MAPTCYP2C9ALOX15
SCHEMBL9448705 0.83 SLC2A1 (0.57) ALDH1A1CYP3A4MAPTCYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2775996-B1 USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS MERCK PATENT GMBH (DE) 2018-02-28 EP disclosed
US-20150051295-A1 USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS MERCK PATENT GMBH (DE) 2015-02-19 US disclosed
US-20150051295-A1 USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS MERCK PATENT GMBH (DE) 2015-02-19 US disclosed
WO-2013045098-A2 USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS MERCK PATENT GMBH (DE) 2013-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051295-A1 USE OF PROPANOL AND PROPENOL DERIVATIVES AS ANTIOXIDANTS GPX4, EBP, CAT ALDH1A1 134/4885CYP3A4 233/4885MAPT 1598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.